Institute for Behavioral Health
Schneider Institutes for Health Policy
The Heller School for Social Policy and Management at Brandeis University
Aiming to increase recognition of the way behaviors impact health, and to work with systems and organizations to design processes and approaches that improve the overall health of the population.
CONSTANCE M. HORGAN, SC.D.
Since the Heller School began, both faculty and students have studied mental and substance use disorders. Formalized in 2003, IBH focuses on the intersection of health, behavior, and systems of care, with an emphasis on their linkages. Its underlying premise is that these systems can be better used to promote healthier lifestyles and assist individuals to engage in behaviors which lead to better health.
Our focus is broadening to include other issues that are affected by behaviors which can be targeted by interventions and have an impact on health and wellness. In addition to studying systems of care, we investigate health outcomes that are associated with behaviors, and also develop and test methods to evaluate the effects of behaviors on health.
We consider a variety of systems of care, including health care delivery, as well as criminal justice, education, social services, housing, military and the workplace.
We hope that you find this site useful as you learn more about our research staff and our activities in behavioral health.
The Opioid Crisis – A Critical Threat Across The U.S. - Why Health Services Research Matters, this session has been accepted for oral presentation at Academy Health in a Panel on Critical and Emerging Issues in Health Services Research (HSR). The conference this year will be held in New Orleans, LA, June 25-27. This session is co-sponsored by the Brandeis-Harvard NIDA Center to Improve the System Performance of Substance Use Disorders (P30 DA035772) and the Brandeis Opioid Policy Research Collaborative at the Institute for Behavioral Health. Panel members: Andrew Kolodny, MD, Peter Kreiner, Ph.D., Sharon Reif, Ph.D. (Brandeis) and Richard Frank, Ph.D. (Harvard).
IBH researchers in the news:
Tom Clark is quoted in this Washington Post article, New state rules are forcing opioid prescribers to confront doctor shopping.
Peter Kreiner & Andrew Kolodny
S Reif, TB Creedon, CM Horgan, MT Stewart, DW. Garnick. (2017) Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014, Journal of Psychoactive Drugs , published online ahead of print.
Trotter Davis M, Bateman B, Avorn J. (2017) Educational Outreach to Opioid Prescribers: The Case for Academic Detailing. Pain Physician. (2S):S147-S151.
Brolin M, Torres M, Hodgkin D, Horgan C, Lee M, Merrick E, Ritter G, Panas L, DeMarco N, Hopwood J, Gewirtz A, Straus J, Harrington J, Lane N. (2017) Implementation of Client Incentives within a Recovery Navigation Program. J Subst Abuse Treat. 2017 Jan;72:25-31. doi: 10.1016/j.jsat.2016.09.003.
Johnson J, Hodgkin D, Harris SK. (2017) The design of medical marijuana laws and adolescent use and heavy use of marijuana: Analysis of 45 states from 1991 to 2011. Drug Alcohol Depend. (2017) 170:1-8. PMCID: PMC5183555
Lin DH, Lucas E, Murimi IB, Kolodny A, Alexander GC. (2017) Financial Conflicts of Interest and the Centers for Disease Control and Prevention's 2016 Guideline for Prescribing Opioids for Chronic Pain. JAMA Intern Med, 177(3):427-428. doi: 10.1001/jamainternmed.2016.8471.